Cargando…
A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain
Agonists at the δ opioid receptor are known to be potent antihyperalgesics in chronic pain models and effective in models of anxiety and depression. However, some δ opioid agonists have proconvulsant properties while tolerance to the therapeutic effects can develop. Previous evidence indicates that...
Autores principales: | Conibear, Alexandra E., Asghar, Junaid, Hill, Rob, Henderson, Graeme, Borbely, Eva, Tekus, Valeria, Helyes, Zsuzsanna, Palandri, Josephine, Bailey, Chris, Starke, Ingemar, von Mentzer, Bengt, Kendall, David, Kelly, Eamonn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978697/ https://www.ncbi.nlm.nih.gov/pubmed/31594792 http://dx.doi.org/10.1124/jpet.119.258640 |
Ejemplares similares
-
In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST(4) Receptor Agonists
por: Kántás, Boglárka, et al.
Publicado: (2021) -
Exploratory and locomotor activity, learning and memory functions in somatostatin receptor subtype 4 gene-deficient mice in relation to aging and sex
por: Szentes, Nikolett, et al.
Publicado: (2019) -
The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers
por: Soares, Holly D., et al.
Publicado: (2016) -
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects
por: Toyn, Jeremy H., et al.
Publicado: (2016) -
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain
por: Kostich, Walter, et al.
Publicado: (2016)